Month: <span>June 2018</span>

Home / 2018 / June
Post

Semaglutide found to be effective against type 2 diabetes

Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review published online May 13 in Diabetes, Obesity and Metabolism. Panagiotis Andreadis, M.D., from the Aristotle University of Thessaloniki in Greece, and colleagues conducted a systematic literature review to identify randomized controlled trialscomparing semaglutide with placebo or other antidiabetic agents. The primary outcome was...

Post

Pharmacists should counsel patients fasting for Ramadan

(HealthDay)—Pharmacists should counsel Muslim patients who fast during Ramadan with respect to their medications and adjusting their medication regimen, according to an article published in Drug Topics. Muslims who observe the fast of Ramadan will refrain from consuming anything by mouth between dawn and sunset, including oral medications. Pharmacists can counsel their patients by recommending medication adjustments and...

Post

Phantom: The first ultrasound for Mac

Phantom transforms your Mac into a point-of-care ultrasound kit. It accurately captures high-quality imagery of abdominal and pelvic windows with a reliable, multi-application probe, and generates complex side-by-side measurements and calculations that can be stored and shared directly from your Mac. Its collaborative features provide start to finish productivity from capturing images to annotating, sharing, even...

Post

FDA Approves Lucemyra, The First Non-Opioid Drug For Opioid Withdrawal Symptoms Up To 14 Days

Withdrawal symptoms from opioids are often very difficult to manage, but the approval of a new treatment could change all of that for patients. The Food and Drug Administration approved of Lucemyra, a treatment for adults suffering from opioid withdrawal symptoms. It has been approved for patients to use up to 14 days. What Drug...

Post

What Are STAP Cells (Stimulus-Triggered Acquisition of Pluripotency)?

There has been a lot of clamor and hype surrounding stimulus-triggered acquisition of pluripotency (STAP) cells since their introduction to the research community in 2014. Read this post for a short, succinct summary of the scientific controversy surrounding STAP cells. Defining STAP Cells In this article: What Is It About Background of Stapcells The Controversy...